Contrast agent-enhanced magnetic resonance imaging of skeletal muscle damage in animal models of muscular dystrophy

Magnetic Resonance in Medicine

Volumn 44, Issue 4, 2000, Pages 655-659

  Straub, Volker ^a   Donahue, Kathleen M ^b   Allamand, Valérie ^a   Davisson, Robin L ^a   Kim, Young R ^b   Campbell, Kevin P ^a  

^a UNIVERSITY OF IOWA   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Dystrophin; MRI; Muscular dystrophy; Sarcoglycan

Indexed keywords

MAGNETIC RESONANCE IMAGING; MAMMALS;

ANIMAL MODEL; CONTRAST AGENT; DYSTROPHIN; MUSCULAR DYSTROPHY; NON-INVASIVE IMAGING; SARCOGLYCAN; SKELETAL MUSCLE; TARGETED CONTRAST AGENTS;

MUSCLE;

CONTRAST MEDIUM; DYSTROPHIN; GADOFOSVESET; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SARCOGLYCAN;

ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EXPERIMENTAL MODEL; IMAGING SYSTEM; LEG MUSCLE; MUSCLE INJURY; MUSCULAR DYSTROPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SKELETAL MUSCLE;

EID: 0033782272     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/1522-2594(200010)44:4<655::AID-MRM22>3.0.CO;2-T     Document Type: Article

References (32)

1. Duchenne dystrophy: Electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber
2. Segmental fibre breakdown and defects of the plasmalemma in diseased human muscles
3. Duchenne muscular dystrophy: Plasma membrane loss initiates muscle cell necrosis unless it is repaired
4. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin
5. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix
6. Muscular dystrophies and the dystrophin-glycoprotein complex
7. Histopathological changes in Duchenne muscular dystrophy
8. Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector
9. Dystrophin protects the sarcolemma from stresses developed during muscle contraction
10. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption
11. Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice
12. MS-325: A small-molecule vascular imaging agent for magnetic resonance imaging
13. Intravascular contrast agent improves magnetic resonance angiography of carotid arteries in minipigs
14. Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging
15. MS-325: Albumin-targeted contrast agent for MR angiography
16. X chromosome-linked muscular dystrophy (mdx) in the mouse
17. The molecular basis of muscular dystrophy in the mdx mouse: A point mutation
18. Alpha-Sarcoglycan (adhalin) deficiency: Complete deficiency patients are 5% of childhood-onset dystrophin-normal muscular dystrophy and most partial deficiency patients do not have gene mutations
19. Primary adhalinopathy: A common cause of autosomal recessive muscular dystrophy of variable severity
20. Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy
21. Magnetic resonance imaging of regenerating and dystrophic mouse muscle
22. Elevated levels of albumin in soleus and diaphragm muscles of mdx mice
23. Muscle fiber degeneration and necrosis in muscular dystrophy and other muscle diseases: Cytochemical and immunocytochemical data
24. Dystrophin analysis in Duchenne and Becker muscular dystrophy carriers: Correlation with intracellular calcium and albumin
25. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction
26. Steady-state and dynamic MR angiography with MS-325: Initial experience in humans
27. Vital staining, serum albumin and the blood-brain barrier
28. Binding properties of circulating Evans blue in rabbits as determined by disc electrophoresis
29. Quantitative magnetic resonance imaging of the mdx mouse model of Duchenne muscular dystrophy
30. The use of nuclear magnetic resonance to evaluate muscle injury
31. In vivo quantification of the unidirectional influx constant for Gd-DTPA diffusion across the myocardial capillaries with MR imaging
32. Factors in myocardial 'perfusion' imaging with ultra-fast MRI and Gd-DTPA administration